To assess the clinical value of procedures for treating adults with dental agenesis due to rare genetic diseases in order to advise French National Health Insurance (NHI) on the reimbursement of these procedures. The present assessment was carried out within the framework of the Rare Diseases Programme set up by the French Ministry of Health and Solidarity
|